6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals

Despite some ups and downs, Johnson & Johnson's (NYSE: JNJ) pharmaceutical division consistently outperforms its peers in terms of branded drug sales. As a result, pharmaceutical sales are now responsible for a majority of the healthcare conglomerate's total revenue.